10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,360,000 | -37.1% | 750,000 | 0.0% | 100.00% | 0.0% |
| Q2 2022 | $33,938,000 | -40.5% | 750,000 | 0.0% | 100.00% | +0.3% |
| Q1 2022 | $57,053,000 | -48.9% | 750,000 | 0.0% | 99.71% | +0.0% |
| Q4 2021 | $111,720,000 | +2.3% | 750,000 | 0.0% | 99.68% | +16.7% |
| Q3 2021 | $109,185,000 | -25.7% | 750,000 | 0.0% | 85.42% | -3.5% |
| Q2 2021 | $146,865,000 | -18.9% | 750,000 | -25.0% | 88.53% | -3.0% |
| Q1 2021 | $181,000,000 | +2.3% | 1,000,000 | -20.0% | 91.29% | -2.0% |
| Q4 2020 | $177,000,000 | -48.4% | 1,250,000 | -54.5% | 93.12% | -3.5% |
| Q3 2020 | $342,870,000 | +9.7% | 2,750,000 | -21.4% | 96.54% | -2.0% |
| Q2 2020 | $312,585,000 | -13.3% | 3,500,000 | -39.5% | 98.53% | -1.3% |
| Q1 2020 | $360,728,000 | -34.6% | 5,788,317 | -20.0% | 99.80% | -0.1% |
| Q4 2019 | $551,699,000 | – | 7,235,396 | – | 99.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |